• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

支架治疗恶性胆道梗阻的进展。

Advances in stent therapy for malignant biliary obstruction.

机构信息

Department of Gastroenterology, The First Affiliated Hospital of Nanchang University, Nanchang, 330006, Jiangxi, China.

Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education), Department of Liver Surgery and Transplantation, Zhongshan Hospital, Liver Cancer Institute, Fudan University, Shanghai, 200032, China.

出版信息

Abdom Radiol (NY). 2021 Jan;46(1):351-361. doi: 10.1007/s00261-020-02593-5.

DOI:10.1007/s00261-020-02593-5
PMID:32451676
Abstract

Malignant biliary obstruction (MBO), result of pancreatobiliary diseases is a challenging condition. Most patients with MBO are inoperable at the time of diagnosis, and the disease is poorly controlled using external-beam radiotherapy and chemotherapy. Biliary stent therapy emerged as a promising strategy for alleviating MBO and prolonging life. However, physicians find it difficult to determine the optimal type of biliary stent for the palliation of MBO. Here, we review the safety and efficacy of available biliary stents, used alone or in combination with brachytherapy, photodynamic therapy and advanced chemotherapeutics, in patients with pancreatobiliary malignancies and put forward countermeasures involving stent obstruction. Furthermore, 3D-printing stents and nanoparticle-loaded stents have broad application prospects for fabricating tailor-made biliary stents.

摘要

恶性胆道梗阻(MBO)是由胰胆疾病引起的一种具有挑战性的疾病。大多数 MBO 患者在诊断时无法进行手术,并且使用外照射放疗和化疗难以有效控制病情。胆道支架治疗作为缓解 MBO 和延长生命的一种有前途的策略已经出现。然而,医生发现很难确定用于缓解 MBO 的最佳类型的胆道支架。在这里,我们回顾了单独使用或与近距离放射治疗、光动力疗法和先进化疗联合使用的各种胆道支架在胰胆恶性肿瘤患者中的安全性和有效性,并提出了涉及支架阻塞的对策。此外,3D 打印支架和载药纳米颗粒支架在制造定制胆道支架方面具有广阔的应用前景。

相似文献

1
Advances in stent therapy for malignant biliary obstruction.支架治疗恶性胆道梗阻的进展。
Abdom Radiol (NY). 2021 Jan;46(1):351-361. doi: 10.1007/s00261-020-02593-5.
2
Irradiation stents vs. conventional metal stents for unresectable malignant biliary obstruction: A multicenter trial.不可切除恶性胆道梗阻的放疗支架与传统金属支架的比较:一项多中心试验。
J Hepatol. 2018 May;68(5):970-977. doi: 10.1016/j.jhep.2017.12.028. Epub 2018 Jan 10.
3
Endoscopic intraluminal brachytherapy and metal stent in malignant hilar biliary obstruction: a pilot study.内镜腔内近距离放射治疗与金属支架治疗恶性肝门部胆管梗阻:一项初步研究。
Liver Int. 2007 Apr;27(3):347-52. doi: 10.1111/j.1478-3231.2006.01439.x.
4
Endoscopic therapy in the management of malignant biliary obstruction.内镜治疗在恶性胆管梗阻管理中的应用
Eur J Surg Oncol. 2008 Mar;34(3):313-7. doi: 10.1016/j.ejso.2007.07.210. Epub 2008 Feb 13.
5
Percutaneous transhepatic self-expanding metal stents for palliation of malignant biliary obstruction.经皮经肝自膨式金属支架用于恶性胆道梗阻的姑息治疗。
S Afr J Surg. 2012 Jul 11;50(3):54, 56, 58 passim. doi: 10.7196/sajs.1302.
6
Management of malignant biliary obstruction: nonoperative and palliative techniques.恶性胆管梗阻的管理:非手术及姑息治疗技术
Oncology (Williston Park). 1995 Jun;9(6):493-6, 499; discussion 499-500, 503.
7
Comparative efficacy and safety of local palliative therapeutics for unresectable malignant biliary obstruction: a Bayesian network meta-analysis.不可切除恶性胆道梗阻局部姑息性治疗的疗效和安全性比较:贝叶斯网状Meta 分析。
Expert Rev Gastroenterol Hepatol. 2022 Jun;16(6):555-567. doi: 10.1080/17474124.2022.2085090. Epub 2022 Jun 14.
8
Effectiveness of combined biliary and duodenal stenting in patients with malignant biliary and duodenal obstruction.胆道和十二指肠联合支架置入术治疗恶性胆道和十二指肠梗阻患者的疗效
Scand J Gastroenterol. 2012 Sep;47(8-9):962-7. doi: 10.3109/00365521.2012.677956. Epub 2012 May 10.
9
Stent performance in palliative transhepatic treatment of malignant biliary obstruction: a randomized study comparing covered versus uncovered stents.覆膜支架与非覆膜支架在恶性胆管梗阻姑息性经肝治疗中的支架性能:一项随机对照研究
Acta Radiol. 2020 Dec;61(12):1591-1599. doi: 10.1177/0284185120911187. Epub 2020 Mar 25.
10
Metallic stents in malignant biliary obstruction: prospective long-term clinical results.金属支架治疗恶性胆管梗阻:前瞻性长期临床结果
AJR Am J Roentgenol. 1997 Mar;168(3):741-5. doi: 10.2214/ajr.168.3.9057527.

引用本文的文献

1
Overview of endoscopic biliary stenting in malignant obstructive jaundice.恶性梗阻性黄疸的内镜下胆道支架置入术概述
World J Gastrointest Surg. 2025 Feb 27;17(2):103378. doi: 10.4240/wjgs.v17.i2.103378.
2
Radiation-emitting metallic stent for unresectable Bismuth type III or IV perihilar cholangiocarcinoma: a multicenter randomized trial.用于不可切除的Bismuth III型或IV型肝门部胆管癌的放射性金属支架:一项多中心随机试验
Int J Surg. 2025 Jan 1;111(1):706-717. doi: 10.1097/JS9.0000000000002089.
3
Risk factors for acute pancreatitis post percutaneous transhepatic biliary stenting in patients with distal malignant obstruction.

本文引用的文献

1
Gadolinium-Based Nanoparticles for Theranostic MRI-Guided Radiosensitization in Hepatocellular Carcinoma.用于肝细胞癌中磁共振成像引导的放射增敏治疗的钆基纳米颗粒
Front Bioeng Biotechnol. 2019 Nov 27;7:368. doi: 10.3389/fbioe.2019.00368. eCollection 2019.
2
Effect of an educational intervention on colonoscopy quality outcomes.教育干预对结肠镜检查质量结果的影响。
Surg Endosc. 2020 Nov;34(11):5142-5147. doi: 10.1007/s00464-019-07304-w. Epub 2019 Dec 9.
3
Progression of pancreatic cystic lesions without any risk features is associated with initial cyst size and obesity.
远端恶性梗阻患者经皮经肝胆道支架置入术后急性胰腺炎的危险因素
Quant Imaging Med Surg. 2024 Sep 1;14(9):6508-6516. doi: 10.21037/qims-24-431. Epub 2024 Aug 7.
4
Factors related to stent patency and early elimination of jaundice using bile duct stent combined with iodine-125 seed implantation in malignant obstructive jaundice.恶性梗阻性黄疸中胆管支架联合碘-125粒子植入术与支架通畅及黄疸早期消退相关的因素
J Contemp Brachytherapy. 2022 Dec;14(6):542-550. doi: 10.5114/jcb.2022.123974. Epub 2022 Dec 30.
5
Risk Factors Associated with Acute Pancreatitis after Percutaneous Biliary Intervention: We Do Not Know Nearly Enough.经皮胆道介入术后急性胰腺炎的相关危险因素:我们所知甚少。
Gastroenterol Res Pract. 2023 Jan 6;2023:9563074. doi: 10.1155/2023/9563074. eCollection 2023.
6
Futuristic Developments and Applications in Endoluminal Stenting.腔内支架置入术的未来发展与应用
Gastroenterol Res Pract. 2022 Jan 11;2022:6774925. doi: 10.1155/2022/6774925. eCollection 2022.
7
Sulfasalazine Sensitizes Polyhematoporphyrin-Mediated Photodynamic Therapy in Cholangiocarcinoma by Targeting xCT.柳氮磺胺吡啶通过靶向xCT使胆管癌对多血卟啉介导的光动力疗法敏感。
Front Pharmacol. 2021 Aug 13;12:723488. doi: 10.3389/fphar.2021.723488. eCollection 2021.
8
Endoscopic retrograde cholangiopancreatography drainage for palliation of malignant hilar biliary obstruction - stent-in-stent or side-by-side? A systematic review and meta-analysis.内镜逆行胰胆管造影引流术治疗恶性肝门部胆管梗阻的姑息治疗——支架套叠还是并排放置?一项系统评价和荟萃分析。
World J Hepatol. 2021 May 27;13(5):595-610. doi: 10.4254/wjh.v13.i5.595.
胰腺囊性病变无任何风险特征的进展与初始囊肿大小和肥胖有关。
J Gastroenterol Hepatol. 2020 May;35(5):877-884. doi: 10.1111/jgh.14940. Epub 2019 Dec 11.
4
Moving the Needle Forward With Locoregional Treatment in Unresectable Cholangiocarcinoma-The Jury Is Still Out.通过局部区域治疗推动不可切除胆管癌治疗进展——尚无定论
JAMA Oncol. 2020 Jan 1;6(1):29-31. doi: 10.1001/jamaoncol.2019.3691.
5
Percutaneous stenting and chemotherapy for unresectable pancreatic cancer: Comparison of irradiation stents vs conventional metal stents.经皮支架置入术联合化疗治疗不可切除胰腺癌:放疗支架与传统金属支架的比较。
Pancreatology. 2019 Oct;19(7):957-962. doi: 10.1016/j.pan.2019.09.006. Epub 2019 Sep 18.
6
Development of a Model to Predict Portal Vein Thrombosis in Liver Transplant Candidates: The Portal Vein Thrombosis Risk Index.开发一种预测肝移植候选者门静脉血栓形成的模型:门静脉血栓形成风险指数。
Liver Transpl. 2019 Dec;25(12):1747-1755. doi: 10.1002/lt.25630. Epub 2019 Sep 19.
7
Superiority of endoscopic interventions over minimally invasive surgery for infected necrotizing pancreatitis: meta-analysis of randomized trials.内镜介入优于微创外科治疗感染性坏死性胰腺炎:随机试验的荟萃分析。
Dig Endosc. 2020 Mar;32(3):298-308. doi: 10.1111/den.13470. Epub 2019 Aug 1.
8
Partially Covered Versus Uncovered Self-Expandable Metal Stents: Coating Nor Diameter Affect Clinical Outcomes.部分覆膜与非覆膜自膨式金属支架:涂层与否及直径均不影响临床结局。
Dig Dis Sci. 2019 Sep;64(9):2631-2637. doi: 10.1007/s10620-019-05643-1. Epub 2019 Apr 30.
9
Causes of hOCT1-Dependent Cholangiocarcinoma Resistance to Sorafenib and Sensitization by Tumor-Selective Gene Therapy.hOCT1 依赖性胆管癌对索拉非尼耐药的原因及肿瘤选择性基因治疗的增敏作用。
Hepatology. 2019 Oct;70(4):1246-1261. doi: 10.1002/hep.30656. Epub 2019 May 20.
10
Piperlongumine-Eluting Gastrointestinal Stent Using Reactive Oxygen Species-Sensitive Nanofiber Mats for Inhibition of Cholangiocarcinoma Cells.使用活性氧敏感纳米纤维垫的胡椒碱洗脱胃肠道支架用于抑制胆管癌细胞
Nanoscale Res Lett. 2019 Feb 18;14(1):58. doi: 10.1186/s11671-019-2887-0.